首页> 美国卫生研究院文献>EBioMedicine >Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305]

【2h】

Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305]

机译：“辅助概念中的精准医学：膜联蛋白A5 M2单倍型作为抗栓剂治疗以改善妊娠结局的生物标志物的多中心观察治疗队列研究”更正[EBioMedicine 10（2016）299-305]

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 EBioMedicine
作者
Simon Fishel; Deborah Baker; Janine Elson; Maha Ragunath; Glenn Atkinson; Adel Shaker; Ahmed Omar; Rahnuma Kazem; Ashley Beccles; Ian A. Greer;
展开▼
作者单位

展开▼
年(卷),期 2014(13),
年度 2014
页码 365
总页数 1
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献

1. Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome EDITORIAL COMMENT [J] . Keefe David Obstetrical and gynecological survey . 2018,第9期

机译：辅助概念的精确药物：膜蛋白A5M2单倍型的多中心观察治疗队列研究，作为改善妊娠结局的抗血栓处理的生物标志物编辑评论
2. Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome EDITORIAL COMMENT [J] . Keefe David Obstetrical and gynecological survey . 2018,第9期

机译：辅助概念的精确药物：膜蛋白A5M2单倍型的多中心观察治疗队列研究，作为改善妊娠结局的抗血栓处理的生物标志物编辑评论
3. Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome [J] . Simon Fishel, Deborah Baker, Janine Elson, EBioMedicine . 2016,第2期

机译：辅助概念中的精准医学：膜联蛋白A5 M2单倍型作为抗血栓治疗以改善妊娠结局的生物标志物的多中心观察治疗队列研究
4. Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome [O] . Simon Fishel, Deborah Baker, Janine Elson, 2016

机译：辅助概念中的精准医学：膜联蛋白A5 M2单倍型作为抗血栓治疗以改善妊娠结局的生物标志物的多中心观察治疗队列研究
5. Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305] [O] . Simon Fishel, Deborah Baker, Janine Elson, 2016

机译：“辅助概念中的精确医学：多中心观察治疗队列研究annexin a5 m2单倍型作为抗血栓治疗改善妊娠结局的生物标志物”的更正“[EBiomedicine 10（2016）299-305]

Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305]

著录项

引文网络

相似文献

相关主题

期刊订阅